Literature DB >> 3121513

Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo.

G M Zhong1, E M Peterson, C W Czarniecki, L M de la Maza.   

Abstract

Chlamydia trachomatis serovar L1 injected intravenously in mice resulted in systemic nonlethal infections of the animals. Treatment of mice with recombinant murine gamma interferon resulted in a decrease in the number of infectious C. trachomatis organisms recovered from the lungs, spleens, and livers as well as in a decrease of the inflammatory reaction in those organs when assessed 3 and 5 days after challenge.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3121513      PMCID： PMC259272          DOI： 10.1128/iai.56.1.283-286.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  14 in total

1.  Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.

Authors:  C D Rothermel; B Y Rubin; E A Jaffe; H W Murray
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

2.  Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.

Authors:  C D Rothermel; B Y Rubin; H W Murray
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

3.  Inhibition of TRIC agents by virus-induced interferon.

Authors:  L Hanna; T C Merigan; E Jawetz
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

4.  Cytochemical Assay of Interferon Produced by Duck Hepatitis Virus.

Authors:  E A Sueltenfuss; M Pollard
Journal:  Science       Date:  1963-02-15       Impact factor: 47.728

5.  Systemic Chlamydia trachomatis infection in mice: a comparison of lymphogranuloma venereum and trachoma biovars.

Authors:  R C Brunham; C Kuo; W J Chen
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

6.  Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Chlamydia trachomatis.

Authors:  J Kazar; J D Gillmore; F B Gordon
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

7.  Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse.

Authors:  D M Williams; J Schachter; D J Drutz; C V Sumaya
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

8.  Ultrastructural analysis of the growth cycle of Chlamydia trachomatis in mouse cells treated with recombinant human alpha-interferons.

Authors:  L M de la Maza; J M Goebel; C W Czarniecki; E M Peterson
Journal:  Exp Mol Pathol       Date:  1984-10       Impact factor: 3.362

9.  The anti-chlamydial and anti-proliferative activities of recombinant murine interferon-gamma are not dependent on tryptophan concentrations.

Authors:  L M de la Maza; E M Peterson; C W Fennie; C W Czarniecki
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.

Authors:  H W Murray; G L Spitalny; C F Nathan
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422
View more
  26 in total

1.  Cleavage of host keratin 8 by a Chlamydia-secreted protease.

Authors:  Feng Dong; Heng Su; Yanqing Huang; Youmin Zhong; Guangming Zhong
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

3.  Presence of gamma interferon in human acute and congenital toxoplasmosis.

Authors:  J Raymond; M H Poissonnier; P H Thulliez; F Forestier; F Daffos; P Lebon
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 4.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

5.  Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection.

Authors:  N Barteneva; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.

Authors:  Chunmei Cheng; Pooja Jain; Ilham Bettahi; Sukumar Pal; Delia Tifrea; Luis M de la Maza
Journal:  Vaccine       Date:  2011-07-08       Impact factor: 3.641

Review 7.  Animal models in interferon research: some current trends.

Authors:  H Schellekens
Journal:  Experientia       Date:  1989-06-15

8.  Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection.

Authors:  Y Fan; S Wang; X Yang
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

9.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis.

Authors:  A J Stagg; W A Elsley; M A Pickett; M E Ward; S C Knight
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.